- Q2 2023 OpGen Inc Earnings Call TranscriptAug 10, 2023$3.38 (-23.42%)Earnings
- Q1 2023 OpGen Inc Earnings Call TranscriptMay 15, 2023$7 (-6.91%)Earnings
- Q4 2022 OpGen Inc Earnings Call TranscriptMar 29, 2023$13.6 (-6.85%)Earnings
- Q3 2022 OpGen Inc Earnings Call TranscriptNov 10, 2022$37 (+4.17%)Earnings
- Q2 2022 OpGen Inc Earnings Call TranscriptAug 11, 2022$126 (+5.00%)Earnings
- Q1 2022 OpGen Inc Earnings Call TranscriptMay 12, 2022$71.52 (+12.52%)Earnings
- Q4 2021 OpGen Inc Earnings Call TranscriptMar 29, 2022$170 (+10.68%)Earnings
- Q3 2021 OpGen Inc Earnings Call TranscriptNov 11, 2021$340Earnings
- Q2 2021 OpGen Inc Earnings Call TranscriptAug 12, 2021$508 (-7.30%)Earnings
- Q1 2021 OpGen Inc Earnings Call TranscriptMay 13, 2021$398 (-11.56%)Earnings
- Q4 2020 OpGen Inc Earnings Call TranscriptMar 25, 2021$540 (-0.74%)Earnings
- Q3 2020 OpGen Inc Earnings Call TranscriptNov 11, 2020$458 (+7.01%)Earnings
- Q2 2020 OpGen Inc Earnings Call TranscriptAug 12, 2020$522 (+1.95%)Earnings
- Q1 2020 OpGen Inc Earnings Call TranscriptMay 07, 2020$448 (-0.44%)Earnings
- Q4 2019 OpGen Inc Earnings Call TranscriptMar 24, 2020$598 (-4.47%)Earnings
- Q3 2019 OpGen Inc Earnings Call TranscriptNov 06, 2019$264 (+3.94%)Earnings
- OpGen Inc and Curetis NV Enter Into Definitive Agreement to Combine Businesses - M&A Call TranscriptSep 04, 2019
- Q2 2019 OpGen Inc Earnings Call TranscriptAug 07, 2019$1300 (+4.57%)Earnings
- Q1 2019 OpGen Inc Earnings Call TranscriptMay 14, 2019$1720 (-11.52%)Earnings
- Q4 2018 OpGen Inc Earnings Call TranscriptFeb 26, 2019$5760 (-4.00%)Earnings
Q3 2022 OpGen Inc Earnings Call Transcript
Welcome to the OpGen Third Quarter 2022 Earnings Call and Business Update. Today, OpGen management will provide an update on the company's current business and outlook for the future. Following OpGen's prepared remarks, there will be a live Q&A session. As a reminder, this conference call is being recorded today, November 10, 2022. (Operator Instructions)
At this time, we will turn the call over to Alyssa Factor, OpGen's IR representatives, to provide opening statements.
Good afternoon, everyone, and thank you, operator, for the introduction. Before we begin, I would like to note that any comments made by management during this conference call may contain forward-looking statements regarding the operations and future results of OpGen, including its subsidiary Curetis and Ares Genetics.
I encourage you to review OpGen's filings with the Securities and Exchange Commission, including, without limitation, the company's most recent Form 10-K and Form 10-Q for
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)